Discover Allurion Technologies' Q1 2025 earnings highlights, featuring a revamped B2B2C strategy, FDA progress, improved margins, and future growth plans.

The unintentional theme of today’s issue is the struggle for control over how we implement AI in the U.S. On one side, where ...

The U.S. Digital Therapeutics Market encompasses software-driven solutions designed to prevent, manage, and treat medical conditions and diseases through evidence-based, clinically validated digital ...

"By combining internal, pre-clinical experimental data, with real-world data from Tempus on its AI-powered platform, we can profoundly deepen our understanding of cancer biology and accelerate our ...

Tech companies are focusing on AI products over research, say industry experts, who are sounding the alarm about safety.

Read about the move to scale use of AI across all FDA centers by the end of June and learn more about future plans to expand ...